baltimore conference logo
  • MJHLS Brand Logo

© 2021 MJH Life Sciences™ , Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways. All rights reserved.

Cased Based Peer Perspectives

Case-Based Peer Perspectives

Targeted Oncology presents Case-Based Peer Perspectives. In each video, expert physicians provide insight on managing oncology-based patient cases that highlight the use of novel agents in clinical practice.

A 76-Year-Old Man With Recurrent Castrate-Sensitive Prostate Cancer
EP. 1: Case Overview: Castrate-Sensitive Prostate Cancer
EP. 2: Managing Castrate-Sensitive Prostate Cancer
EP. 3: Castrate-Sensitive Prostate Cancer: Frontline Therapy
EP. 4: Castrate-Sensitive Prostate Cancer: Treatment Planning
EP. 5: Castrate-Sensitive Prostate Cancer: Second-Line Therapy
EP. 6: Castrate-Sensitive Prostate Cancer: Monitoring Response to Therapy
EP. 7: Castrate-Sensitive Prostate Cancer: TITAN Trial Outcomes
EP. 8: Treatment Advances in Castrate-Sensitive Prostate Cancer
A 68-Year-Old Woman with Small-Cell Lung Cancer
EP. 1: Evaluation of a Patient with Small Cell Lung Cancer
EP. 2: Treatment Options in Small Cell Lung Cancer
EP. 3: Lurbinectedin in the Treatment of Small Cell Lung Cancer
EP. 4: The Future of Treating Small Cell Lung Cancer
A 78-Year-Old Man With Multiple Myeloma
EP. 1: Case Review of a 78-Year-Old Man With Multiple Myeloma
EP. 2: Current First-Line Treatment Options for Transplant-Ineligible Multiple Myeloma
EP. 3: Efficacy Data in the Phase 3 MAIA Study for Multiple Myeloma
EP. 4: Daratumumab + Lenalidomide + Low-Dose Dexamethasone for Patients With Multiple Myeloma
EP. 5: Multiple Myeloma Treatment Amidst COVID-19
EP. 6: Challenges and Unmet Needs in the Treatment of Multiple Myeloma
A 73-Year-Old Male With Mantle Cell Lymphoma
EP. 1: 73-Year-Old Man With Mantle Cell Lymphoma
EP. 2: Frontline Treatment Options in Mantle Cell Lymphoma
EP. 3: Second-Line Treatment Options in Mantle Cell Lymphoma
EP. 4: Results of the ZUMA-2 Trial in Relapsed/Refractory Mantle Cell Lymphoma
EP. 5: Mitigating CAR T–Related Toxicities in Mantle Cell Lymphoma
EP. 6: Role of CAR T-cell Therapy in Mantle Cell Lymphoma
EP. 7: Unmet Needs and Future Directions in Mantle Cell Lymphoma
A 71-Year-Old Man with Gastric Cancer
EP. 1: Evaluation of a Patient With Gastric Cancer
EP. 2: Considerations for Therapy in Gastric Cancer
EP. 3: Second-Line Treatment Options in Gastric Cancer
EP. 4: Beyond Second-Line Therapy in Gastric Cancer
EP. 5: HER2-Positive Gastric Cancer
EP. 6: Understanding the DESTINY-Gastric01 Trial
A 75-Year-Old Woman With Multiple Myeloma
EP. 1: Case Review of a 75-Year-Old Woman with Multiple Myeloma
EP. 2: First-Line Treatment Options and Subsequent Risks Facing Multiple Myeloma Patients
EP. 3: Data Analysis from the Phase 3 MAIA Study
EP. 4: The MAIA & PEGASUS Trial and Managing Patients Receiving DRd
EP. 5: The Impact of COVID-19 on Treating Patients With Multiple Myeloma
EP. 6: Current and Future Treatment Options for Multiple Myeloma Patients